Izidore Lossos, M.D., a hematologist oncologist at the University of Miami Sylvester Comprehensive Cancer Center, is a lead author of a landmark lymphoma study published Thursday, April 29, in the New England Journal of Medicine. The study identifies six genes that can predict whether a person's lymphoma will respond to standard treatment. This finding by researchers at the University of Miami School of Medicine, Stanford University School of Medicine, and Applied Biosystems, could result in the first gene-based screening to identify people who need aggressive therapy.
$300,000 was raised for The University of Miami Sylvester Comprehensive Cancer Center at the kick-off party for the Mysterious Gardens of the Amazon In the Garden Gala, planned for this November 6th, 2004 at the Fontainebleau Hilton Hotel in Miami Beach.
The University of Miami Sylvester Comprehensive Cancer Center is pleased to offer photodynamic therapy for some patients being treated for esophageal and lung cancer, a treatment which was not available in South Florida before now. This non-invasive treatment uses light to treat shallow tumors in sensitive areas of the body, which are difficult to reach with conventional surgery. "Cancer often starts on the surface before it grows deep in the mouth or throat,” said Francisco Civantos, M.D., F.A.C.S., a head and neck surgeon at UM/Sylvester. “The advantage of photodynamic therapy is, you shine the laser at the tumor and it can heal malignant cells in one shot.”